24 May 2013
Keywords: BioPharma landscape, Drug pipelines, Sales g rowth, EvaluatePharma
Article | 19 June 2012
The quantity of biologic drugs on the market will likely soar by 2018, according to analysts at Evaluate Pharma, who says ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
19 June 2012
23 May 2013
© 2013 thepharmaletter.com